SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-14-000587
Filing Date
2014-02-14
Accepted
2014-02-14 16:08:05
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q vistagen10q_dec312013.htm 10-Q 1267695
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31_1.htm EX-31.1 9912
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31_2.htm EX-31.2 9986
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS REQUIRED BY RULE ex32.htm EX-32 7667
  Complete submission text file 0001415889-14-000587.txt   6788212

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vsta-20131231.xml EX-101.INS 1040882
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vsta-20131231.xsd EX-101.SCH 67350
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsta-20131231_cal.xml EX-101.CAL 49616
8 XBRL TAXONOMYEXTENSION DEFINITION LINKBASE vsta-20131231_def.xml EX-101.DEF 130006
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsta-20131231_lab.xml EX-101.LAB 337958
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsta-20131231_pre.xml EX-101.PRE 241342
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 14616422
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences